BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Lei Lei, Chao Zhou, Xue Yang, Liangping Li. Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver diseaseClinical and Experimental Pharmacology and Physiology 2018; 45(8): 819 doi: 10.1111/1440-1681.12940
Weaam Gouda, Esmat Ashour, Yehia Shaker, Wafaa Ezzat. MTP genetic variants associated with non-alcoholic fatty liver in metabolic syndrome patientsGenes & Diseases 2017; 4(4): 222 doi: 10.1016/j.gendis.2017.09.002
Anna Alisi, Stefano Cianfarani, Melania Manco, Carlo Agostoni, Valerio Nobili. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environmentAnnals of Medicine 2012; 44(1): 29 doi: 10.3109/07853890.2010.547869
Gabriella Pár, Gábor Horváth, Alajos Pár. Non-alcoholic fatty liver disease and steatohepatitisOrvosi Hetilap 2013; 154(29): 1124 doi: 10.1556/OH.2013.29626
Fernanda Domenici, Helio Vannucchi. Role of Oxidative Stress in Chronic Diseases2014; : 260 doi: 10.1201/b16653-16
Luc Tappy, Kim-Anne Lê. Does fructose consumption contribute to non-alcoholic fatty liver disease?Clinics and Research in Hepatology and Gastroenterology 2012; 36(6): 554 doi: 10.1016/j.clinre.2012.06.005
Wei Zheng, Lu Wang, Xiao Su, Xiao-Fang Hu. MTP −493G>T Polymorphism and Susceptibility to Nonalcoholic Fatty Liver Disease: A Meta-AnalysisDNA and Cell Biology 2014; 33(6): 361 doi: 10.1089/dna.2013.2238
Yuya Seko, Kanji Yamaguchi, Yoshito Itoh. The genetic backgrounds in nonalcoholic fatty liver diseaseClinical Journal of Gastroenterology 2018; 11(2): 97 doi: 10.1007/s12328-018-0841-9
Agnieszka Kempinska-Podhorodecka, Ewa Wunsch, Piotr Milkiewicz, Ewa Stachowska, Malgorzata Milkiewicz. The Association between SOCS1−1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) PatientsJournal of Clinical Medicine 2019; 8(11): 1912 doi: 10.3390/jcm8111912
Bai-Fang Wang, Ying Wang, Ran Ao, Jing Tong, Bing-Yuan Wang. AdipoQT45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta-Analysis and Meta-RegressionJournal of Clinical Laboratory Analysis 2016; 30(1): 47 doi: 10.1002/jcla.21814
Vincent Zimmer, Frank Lammert. Genetics and epigenetics in the fibrogenic evolution of chronic liver diseasesBest Practice & Research Clinical Gastroenterology 2011; 25(2): 269 doi: 10.1016/j.bpg.2011.02.007
Vettickattuparambil George Giby, Thekkuttuparambil Ananthanarayanan Ajith. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver diseaseWorld Journal of Hepatology 2014; 6(8): 570-579 doi: 10.4254/wjh.v6.i8.570
Rohini Mehta, Aybike Birerdinc, Zobair M. Younossi. Host Genetic Variants in Obesity-Related Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease 2014; 18(1): 249 doi: 10.1016/j.cld.2013.09.017
R.B. Prussick, L. Miele. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?British Journal of Dermatology 2018; 179(1): 16 doi: 10.1111/bjd.16239
Karina Banasik, Johanne M. Justesen, Malene Hornbak, Nikolaj T. Krarup, Anette P. Gjesing, Camilla H. Sandholt, Thomas S. Jensen, Niels Grarup, Åsa Andersson, Torben Jørgensen, Daniel R. Witte, Annelli Sandbæk, Torsten Lauritzen, Bernard Thorens, Søren Brunak, Thorkild I. A. Sørensen, Oluf Pedersen, Torben Hansen, Ying Xu. Bioinformatics-Driven Identification and Examination of Candidate Genes for Non-Alcoholic Fatty Liver DiseasePLoS ONE 2011; 6(1): e16542 doi: 10.1371/journal.pone.0016542
Menha Swellam, Nadia Hamdy. Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptorIUBMB Life 2012; 64(2): 180 doi: 10.1002/iub.597